How many insider trades does FilingIQ track for NAUT?

FilingIQ tracks 59 Form 4 insider transactions for NAUT (Nautilus Biotechnology, Inc.), covering filings from May 24, 2021 onwards. 8 of those were filed in the last 90 days.

Are NAUT insiders net buyers or net sellers?

Across the full Form 4 history for NAUT, 44 transactions (75%) were open-market purchases and 2 (3%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does NAUT insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is NAUT in?

Nautilus Biotechnology, Inc. (NAUT) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $330.92M.

NAUT insider trading

NasdaqCM Healthcare

Nautilus Biotechnology, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

75% / 3%

Market cap

$330.92M

About Nautilus Biotechnology, Inc.

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes an end-to-end solution comprising instruments, consumables, and software analysis. It also offers a proteome analysis system, a high-resolution optical imaging system with integrated fluidics and liquid handling sub-system to deposit protein libraries onto a flow cell and to process labeled multi-affinity reagent probe binding and imaging cycles rapidly to decode and quantify the proteins present in biological samples. In addition, the company offers reagent kits, which include sample preparation, flow cells, multi-affinity probe reagents, and instrument buffer system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. and Weill Cornell MedicineQatar have a research collaboration with The Michael J. Fox Foundation to study the connection between the alpha-synuclein (aSyn) protein and Parkinson's disease (PD). Nautilus Biotechnology, Inc. was founded in 2016 and is headquartered in Seattle, Washington.

Company website: www.nautilus.bio

NAUT insider activity at a glance

FilingIQ has scored 59 insider transactions for NAUT since May 24, 2021. The most recent filing in our index is dated Mar 4, 2026.

Across the full history, 44 open-market purchases and 2 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on NAUT insider trades is 53.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live NAUT trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding NAUT

AH Capital Management, L.L.C.

$52.79M · 3.2% of AUM

Frequently asked

How many insider trades does FilingIQ track for NAUT?: FilingIQ tracks 59 Form 4 insider transactions for NAUT (Nautilus Biotechnology, Inc.), covering filings from May 24, 2021 onwards. 8 of those were filed in the last 90 days.
Are NAUT insiders net buyers or net sellers?: Across the full Form 4 history for NAUT, 44 transactions (75%) were open-market purchases and 2 (3%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does NAUT insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is NAUT in?: Nautilus Biotechnology, Inc. (NAUT) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $330.92M.

Methodology & sources

Every NAUT insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.